Valuation Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Delayed Börse Stuttgart 09:16:34 29/09/26 pm AEST			5-day change	1st Jan Change
0.1250 ^EUR	-4.58%		-21.88%	-39.32%

15/08	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07/08	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027
Market Cap ¹	364	358.4	260.1	-
Change	-	-1.53%	-27.42%	-
Enterprise Value (EV) ¹	364	358.4	356.2	385
Change	-	-1.53%	-0.61%	8.1%
P/E	-3.93x	-5.72x	-	-
PBR	-	-	-	-
PEG	-	0.1x	-	-
Capitalization / Revenue	-	-	-	6.68x
EV / Revenue	-	-	-	9.89x
EV / EBITDA	-	-	-	-
EV / EBIT	-	-	-5.29x	-8.12x
EV / FCF	-	-	-6.98x	-9.45x
FCF Yield	-	-	-14.3%	-10.6%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-0.07	-0.04	-	-
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	38.93
EBITDA	-	-	-	-
EBIT ¹	-	-	-67.3	-47.4
Net income	-85.19	-61.48	-	-
Net Debt ¹	-	-	96.08	124.9
Reference price ²	0.2748	0.2288	0.1525	0.1525
Nbr of stocks (in thousands)	1,324,666	1,566,728	1,705,638	-
Announcement Date	31/3/25	15/4/26	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	21.02x	7.45x	14.97x	1.41%	71.81B
ARGENX SE	31.2x	8.99x	28.02x	0.04%	60.06B
WUXI BIOLOGICS (CAYMAN) INC.	32.35x	6.9x	17.92x	-.--%	27.93B
INSMED INCORPORATED	-72.02x	13.86x	-70.68x	-.--%	25.7B
BIONTECH SE	-15.29x	5.82x	-7.32x	-.--%	24.89B
GENMAB A/S	28.77x	5.41x	17.98x	-.--%	20.92B
PHARMAESSENTIA CORPORATION	42.74x	15.97x	32.4x	0.35%	15.04B
EXELIXIS, INC.	18.03x	5.37x	12.55x	-.--%	14.46B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	990.12x	34.59x	597.44x	-.--%	13.87B
Average	119.66x	11.60x	71.48x	0.2%	30.52B
Weighted average by Cap.	62.96x	9.76x	38.56x	0.4%